CAMBRIDGE, Mass., Aug. 25, 2022 -- Aktis Oncology, a biotechnology company discovering and developing novel classes of targeted alpha radiopharmaceuticals to treat a broad range of solid tumors, today announced...
Art Pappas will speak about future trends in biotechnology at the Charlotte Biotechnology Conference in Charlotte, NC
News | 10. 27. 2010
